Papers: 10.1371/journal.pone.0253335

https://doi.org/10.1371/journal.pone.0253335

Real-world outcomes of first- and second-generation tyrosine kinase inhibitors first-line in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer: A retrospective observational cohort study

Cited by: 3
Author(s): Wei-Wei Ng, Ching‐Long Lin, Ching-Yuan Cheng, Jiunn-Song Jiang, Shu Huei Kao, Diana Yeh
Published: about 4 years ago

Software Mentions 1